Related Experiment Video
Updated: Jun 22, 2026
08:40
An ELISA Based Binding and Competition Method to Rapidly Determine Ligand-receptor Interactions
Published on: March 14, 2016
Receptor density is key to the alpha2/beta interferon differential activities
Ignacio Moraga1, Daniel Harari, Gideon Schreiber
1Institut Pasteur, Unit of Cytokine Signaling, CNRS URA 1961, Paris, France.
Molecular and Cellular Biology
|July 1, 2009
Summary
Type I interferons (IFN-alpha/beta) exhibit varied potency based on cell receptor levels. Higher receptor density enhances IFN-alpha2 potency, influencing cell responses like proliferation and apoptosis.
Area of Science:
- Immunology
- Cell Biology
- Molecular Biology
Background:
- Type I interferons (IFN-alpha/beta) induce diverse cellular responses, including antiviral protection and proliferation inhibition.
- While ligand- and receptor-specific factors are known, cellular determinants of IFN subtype potency remain less understood.
Purpose of the Study:
- To investigate how cellular receptor levels influence the differential potency of IFN-alpha/beta subtypes.
- To analyze the impact of varying interferon receptor density on cellular responses.
Main Methods:
- Utilized human fibrosarcoma U5A-derived clones with graded interferon receptor expression.
- Monitored Jak/Stat signaling, gene induction, cell cycle progression, and apoptosis in response to IFN-alpha2 and IFN-beta.
Main Results:
- IFN-beta showed greater antiproliferative potency than IFN-alpha2 in cells with low receptor levels.
- In cells with high receptor density, IFN-alpha2 matched or exceeded IFN-beta in all measured cellular responses.
Conclusions:
- Cell surface receptor density is a critical cellular determinant of differential type I interferon subtype potency.
- Interferon subtype activity is influenced by both ligand-receptor binding kinetics and receptor abundance on the cell surface.
More Related Videos
08:26Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α
Published on: June 14, 2018
10:00High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Published on: March 24, 2015
Related Concept Videos
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:30Spare Receptors
Some receptors remain unoccupied even when an agonist produces a maximal response. Such empty ones are called spare receptors. In presence of spare receptors the maximum effect of an agonist drug is achieved with fewer than 100% of the receptors being occupied. To determine the presence of spare receptors, scientists often compare the concentration of the drug needed to produce 50% of the maximum effect (EC50) with the concentration of the drug needed to occupy 50% of the receptors (Kd). If the...
01:29The Two-State Receptor Model
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
The binding affinity of a drug determines its interaction with one...
01:29Drug-Receptor Interactions
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
01:30Quantitative Aspects of Drug-Receptor Interaction
The receptor occupancy theory connects a drug's response to the number of occupied receptors. With higher drug concentrations, more receptors are occupied, leading to increased responses. The formation of drug-receptor complexes involves association and dissociation rates, which reach equilibrium when the forward and backward reactions are equal. The equilibrium association constant (Ka) and its inverse, the equilibrium dissociation constant (Kd), indicate drug affinity. Higher Ka and lower Kd...
01:26Adrenergic Receptors: β Subtype
β-adrenoceptors have varied sensitivities towards adrenaline, noradrenaline, and isoprenaline. The order of agonist potency is as follows:
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors have equal affinities for...